摘要
目的 观察中晚期肝癌肝动脉、门静脉双插管栓塞性化疗及在此基础上综合治疗的疗效及生存期。方法 38例肝癌患者随机分为A组 2 0例行肝动脉、门静脉碘油乳化化疗 ;B组 18例双插管碘油乳化化疗 +无水酒精注射 +免疫治疗。结果 A组接受治疗后 1、2、3年的生存期分别是 40 %、15 %、0 % ;B组为 72 %、44%、11% ,统计学上具有显著性意义 ,P <0 .0 5。B组多次化疗者占 83 % (15 /18) ,A组占 45 % (9/2 0 ) ,单次与多次化疗者 1、2、3年生存期分别是2 1%、7%、0 % ;75 %、42 %、8% ,P <0 .0 1。结论 以肝动脉、门静脉双插管碘油乳化化疗 +无水酒精注射 +免疫治疗取得最佳治疗效果和有效的延长生存期 ,是目前综合治疗中晚期肝癌的最佳治疗方法之一。
Objective To observe the clinical effeciency of the treatment for the middle and advanced hapatical Carcinoma with hepatical artery and portal vein of embolism of chemotherapy and together with alcohol injection and immunotherapy.Methods Among 38 cases of advanced hepatical carcinoma,20 cases of group A and 18 cases of group B were perfused with iodine into hepatic artery and portal vein alone or plus alcohol injection and immunotherapy respectively.Results After treatment,the 1 ,2 and 3 year survival rate of group A was 40%,15%,and 0% respectively;while the survival rate of group B were 72%,44%,11% respectively.The difference between two groups was significant.Conclusions Embolization of hepatical artery and portal vein plus alcohol injection and immunotherapy is a good combination in treating patients with advanced hepatical carcinoma. [
出处
《中国肿瘤临床与康复》
2000年第5期20-22,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
肝癌
栓塞
化疗
免疫治疗
hepatical carcinoma
embolism
chemotherapy
immunotherapy
